You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
現代製藥(600420.SH):國藥投資增持144.85萬股
格隆匯 10-25 21:52

格隆匯10月25日丨現代製藥(600420.SH)公佈,公司持股5%以上股東、控股股東一致行動人中國醫藥投資有限公司(以下簡稱“國藥投資”)擬自2018年11月1日至2019年10月25日期間,通過二級市場增持公司股份,增持金額擬不超過人民幣1億元。

截至2019年10月25日增持計劃期滿,國藥投資通過上海證券交易所集中競價交易系統以自有資金1265.77萬元,增持現代製藥股份144.85萬股,佔公司目前總股本的0.14%。

截至2019年10月24日,公司總股本為10.27億股,國藥投資持有公司股份1.74億股,佔公司股份總數的16.94%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account